Literature DB >> 26027526

Oncolytic viruses get a boost with first FDA-approval recommendation.

Elie Dolgin.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26027526     DOI： 10.1038/nrd4643

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  10 in total

Review 1.  Trial Watch-Oncolytic viruses and cancer therapy.

Authors:  Jonathan Pol; Aitziber Buqué; Fernando Aranda; Norma Bloy; Isabelle Cremer; Alexander Eggermont; Philippe Erbs; Jitka Fucikova; Jérôme Galon; Jean-Marc Limacher; Xavier Preville; Catherine Sautès-Fridman; Radek Spisek; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2015-12-08       Impact factor: 8.110

2.  First oncolytic virus approved for melanoma immunotherapy.

Authors:  Jonathan Pol; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2015-12-08       Impact factor: 8.110

Review 3.  Viro-immune therapy: A new strategy for treatment of pancreatic cancer.

Authors:  Andrea Marie Ibrahim; Yao-He Wang
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

Review 4.  Recent advances in oncolytic adenovirus therapies for cancer.

Authors:  Amanda Rosewell Shaw; Masataka Suzuki
Journal:  Curr Opin Virol       Date:  2016-07-02       Impact factor: 7.090

5.  Oncolytic Herpes Virus rRp450 Shows Efficacy in Orthotopic Xenograft Group 3/4 Medulloblastomas and Atypical Teratoid/Rhabdoid Tumors.

Authors:  Adam W Studebaker; Brian J Hutzen; Christopher R Pierson; Kellie B Haworth; Timothy P Cripe; Eric M Jackson; Jeffrey R Leonard
Journal:  Mol Ther Oncolytics       Date:  2017-05-25       Impact factor: 7.200

6.  A Tumor-Targeted Replicating Oncolytic Adenovirus Ad-TD-nsIL12 as a Promising Therapeutic Agent for Human Esophageal Squamous Cell Carcinoma.

Authors:  Zifang Zhang; Chunyang Zhang; Jinxin Miao; Zhizhong Wang; Zhimin Wang; Zhenguo Cheng; Pengju Wang; Louisa S Chard Dunmall; Nicholas R Lemoine; Yaohe Wang
Journal:  Cells       Date:  2020-11-10       Impact factor: 6.600

7.  Oncolytic Viruses in the Therapy of Lymphoproliferative Diseases.

Authors:  P O Vorobyev; F E Babaeva; A V Panova; J Shakiba; S K Kravchenko; A V Soboleva; A V Lipatova
Journal:  Mol Biol       Date:  2022-10-05       Impact factor: 1.540

8.  CD8(+) T-cell Immune Evasion Enables Oncolytic Virus Immunotherapy.

Authors:  Aldo Pourchet; Steven R Fuhrmann; Karsten A Pilones; Sandra Demaria; Alan B Frey; Matthew Mulvey; Ian Mohr
Journal:  EBioMedicine       Date:  2016-01-19       Impact factor: 8.143

9.  Oncolysis by paramyxoviruses: preclinical and clinical studies.

Authors:  Olga V Matveeva; Zong S Guo; Vyacheslav M Senin; Anna V Senina; Svetlana A Shabalina; Peter M Chumakov
Journal:  Mol Ther Oncolytics       Date:  2015-10-21       Impact factor: 7.200

Review 10.  Oncolytic Viruses for Canine Cancer Treatment.

Authors:  Diana Sánchez; Gabriela Cesarman-Maus; Alfredo Amador-Molina; Marcela Lizano
Journal:  Cancers (Basel)       Date:  2018-10-27       Impact factor: 6.639
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.